<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zhps</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал прикладной спектроскопии</journal-title><trans-title-group xml:lang="en"><trans-title>Zhurnal Prikladnoii Spektroskopii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0514-7506</issn><publisher><publisher-name>B. I. Stepanov Institute of Physics of the National Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">zhps-563</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>***</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>***</subject></subj-group></article-categories><title-group><article-title>ОДНОВРЕМЕННОЕ ОПРЕДЕЛЕНИЕ ПАРАЦЕТАМОЛА, ЦИТРАТА ОРФЕНАДРИНА И КОФЕИНА В ТРОЙНОЙ СМЕСИ РАЗЛИЧНЫМИ СПЕКТРОФОТОМЕТРИЧЕСКИМИ МЕТОДАМИ</article-title><trans-title-group xml:lang="en"><trans-title>SIMULTANEOUS DETERMINATION OF PARACETAMOL, ORPHENADRINE CITRATE, AND CAFFEINE TERNARY MIXTURE BY DIFFERENT SPECTROPHOTOMETRIC METHODS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Boltia</surname><given-names>S. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Boltia</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир 11562</p></bio><bio xml:lang="en"><p>Analytical Chemistry Department, Faculty of Pharmacy</p><p>Cairo 11562, Kasr El ـ Aini Str.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Soudi</surname><given-names>A. T.</given-names></name><name name-style="western" xml:lang="en"><surname>Soudi</surname><given-names>A. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир 11562</p></bio><bio xml:lang="en"><p>Analytical Chemistry Department, Faculty of Pharmacy</p><p>Cairo 11562, Kasr El ـ Aini Str.</p></bio><email xlink:type="simple">aya.soudi@pharma.cu.edu.eg</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Elzanfaly</surname><given-names>E. S.</given-names></name><name name-style="western" xml:lang="en"><surname>Elzanfaly</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир 11562</p></bio><bio xml:lang="en"><p>Analytical Chemistry Department, Faculty of Pharmacy</p><p>Cairo 11562, Kasr El ـ Aini Str.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Zaazaa</surname><given-names>H. E.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaazaa</surname><given-names>H. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир 11562</p></bio><bio xml:lang="en"><p>Analytical Chemistry Department, Faculty of Pharmacy</p><p>Cairo 11562, Kasr El ـ Aini Str.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Каирский университет</institution></aff><aff xml:lang="en"><institution>Cairo University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>20</day><month>03</month><year>2020</year></pub-date><volume>86</volume><issue>4</issue><elocation-id>668(1)-668(9)</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Boltia S.A., Soudi A.T., Elzanfaly E.S., Zaazaa H.E., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Boltia S.A., Soudi A.T., Elzanfaly E.S., Zaazaa H.E.</copyright-holder><copyright-holder xml:lang="en">Boltia S.A., Soudi A.T., Elzanfaly E.S., Zaazaa H.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://zhps.ejournal.by/jour/article/view/563">https://zhps.ejournal.by/jour/article/view/563</self-uri><abstract><p>Разрешающая способность математических методов обработки спектрофотометрических данных продемонстрирована на примере одновременного определения сложной тройной смеси парацетамола (PAR), орфенадрина цитрата (Or.cit) и кофеина (CAF), в которой PAR, имеющий самую высокую абсорбционную способность, содержится в очень высокой концентрации по сравнению с Or.cit и CAF. Для разрешения указанных трех препаратов использованы метод одновременного вычитания отношения площадей (SARS), производная спектрофотометрия (D), метод умножения на константу (CM) и метод разрешения с двумя длинами волн (DW). В SARS методе концентрация PAR определялась непосредственно на длине волны 304 нм в спектрах деления с использованием нормированного спектра PAR в качестве делителя. После вычитания константы и умножения на нормализованный спектр PAR содержание CAF и Or.cit можно определить из спектров деления методами первой и четвертой производных. Кроме того, Or.cit и CAF могут быть найдены методами DW и CM после деления спектров отношения на спектр CAF. Предложенные методы обладают хорошей точностью и достоверностью в диапазонах концентраций 20–90, 3–40 и 1–20 мкг/мл для PAR, Or.cit и CAF соответственно. Специфичность предлагаемых методов оценена путем анализа лабораторно приготовленных смесей, содержащих различные соотношения препаратов. Методы успешно применены для определения PAR, Or.cit и CAF в лекарственных формах. Взаимовлияния субстанций не выявлено.</p></abstract><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>метод одновременного вычитания отношения площадей</kwd><kwd>производная спектрофотометрия</kwd><kwd>метод умножения на константу</kwd><kwd>метод двух длин волн</kwd><kwd>парацетамол</kwd><kwd>цитрат орфенадрина</kwd><kwd>кофеин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>simultaneous area ratio subtraction method</kwd><kwd>derivative spectrophotometry</kwd><kwd>constant multiplication method</kwd><kwd>dual wavelength technique</kwd><kwd>paracetamol</kwd><kwd>orphenadrine citrate</kwd><kwd>caffeine</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">This work was funded by Cairo University, Faculty of Pharmacy.</funding-statement><funding-statement xml:lang="en">This work was funded by Cairo University, Faculty of Pharmacy.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">British Pharmacopeia, Her Majesty's Stationary Office, London (2013).</mixed-citation><mixed-citation xml:lang="en">British Pharmacopeia, Her Majesty's Stationary Office, London (2013).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">A. Burke, E. Smyth, G. A. FitzGerald, In: Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 671–716 (2006)</mixed-citation><mixed-citation xml:lang="en">A. Burke, E. Smyth, G. A. FitzGerald, In: Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 671–716 (2006)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Drug Bank, 20 th August, 2017, https://www.drugbank.ca/drugs/DB01173.</mixed-citation><mixed-citation xml:lang="en">Drug Bank, 20 th August, 2017, https://www.drugbank.ca/drugs/DB01173.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">C. P. O’Brien, In: Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 607–628 (2006).</mixed-citation><mixed-citation xml:lang="en">C. P. O’Brien, In: Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 607–628 (2006).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">A. Nazir, Y. Naseer, S. Raza, R. Shahid, Sci. Int. (Lahore), 28, 5215–5218 (2016).</mixed-citation><mixed-citation xml:lang="en">A. Nazir, Y. Naseer, S. Raza, R. Shahid, Sci. Int. (Lahore), 28, 5215–5218 (2016).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">A. P. P. Eisele, D. N. Clausen, C. R. T. Tarley, L. H. Dall’Antonia, E. R. Sartori, Electroanalysis, 25, 1734–1741 (2013).</mixed-citation><mixed-citation xml:lang="en">A. P. P. Eisele, D. N. Clausen, C. R. T. Tarley, L. H. Dall’Antonia, E. R. Sartori, Electroanalysis, 25, 1734–1741 (2013).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">A. M. Yehia, M. K. A. El-Rahman, Spectrochim. Acta, A, 138, 21–30 (2015).</mixed-citation><mixed-citation xml:lang="en">A. M. Yehia, M. K. A. El-Rahman, Spectrochim. Acta, A, 138, 21–30 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">ICH, International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Methodology, ICH-Q2(R1) (2005).</mixed-citation><mixed-citation xml:lang="en">ICH, International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Methodology, ICH-Q2(R1) (2005).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
